Interferon gamma-induced protein 10 (IP-10) for the early prognosis of the risk for severe respiratory failure and death in COVID-19 pneumonia-Reference-Cited by-同舟云学术

Interferon gamma-induced protein 10 (IP-10) for the early prognosis of the risk for severe respiratory failure and death in COVID-19 pneumonia

Published:2023-02 Issue: Volume:162 Page:156111
ISSN:1043-4666
Container-title:Cytokine
language:en
Short-container-title:Cytokine

Author:

Samaras Charilaos,Kyriazopoulou Evdoxia,Poulakou Garyfallia,Reiner Eran,Kosmidou Maria,Karanika Ioanna,Petrakis Vasileios,Adamis George,Gatselis Nikolaos K.,Fragkou Archontoula,Rapti Aggeliki,Taddei Eleonora,Kalomenidis Ioannis,Chrysos George,Bertoli Giulia,Kainis Ilias,Alexiou Zoi,Castelli Francesco,Saverio Serino Francesco,Bakakos Petros,Nicastri Emanuele,Tzavara Vassiliki,Kostis Evangelos,Dagna Lorenzo,Koukidou Sofia,Tzatzagou Glykeria,Chini Maria,Bassetti Matteo,Trakatelli Christina,Tsoukalas George,Selmi Carlo,Samarkos Michael,Pyrpasopoulou Athina,Masgala Aikaterini,Antonakis Emmanouil,Argyraki Aikaterini,Akinosoglou Karolina,Sympardi Styliani,Panagopoulos Periklis,Milionis Haralampos,Metallidis Simeon,Syrigos Konstantinos N.,Angel Alon,Dalekos George N.,Netea Mihai G.,Giamarellos-Bourboulis Evangelos J.

Publisher

Elsevier BV

Subject

Molecular Biology,Hematology,Biochemistry,Immunology,Immunology and Allergy

Reference28 articles.

1. World health Organization (2022). WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int/.

2. Coronavirus Disease 2019 as cause of viral sepsis: a systematic review and meta-analysis;Karakike;Crit. Care Med.,2021

3. Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia;Rovina;Crit. Care,2021

4. An open label trial of anakinra to prevent respiratory failure in COVID-19;Kyriazopoulou;Elife,2021

5. Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial;Kyriazopoulou;Nat. Med.,2021

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MicroRNAs in Sepsis;Biomedicines;2024-09-09

2. Dysregulated Inflammatory Cytokine Levels May Be Useful Markers in a Better Up-Dated Management of COVID-19;Current Issues in Molecular Biology;2024-08-15

3. Towards improved point-of-care (POC) testing for patients with suspected sepsis: POC tests for host biomarkers and possible microbial pathogens;Expert Review of Molecular Diagnostics;2024-08-13

4. IP10 levels refine severity prognostication in COVID-19 and implicate causes of clinical deterioration: lessons for pandemic preparedness;2024-06-16

5. Markers of Inflammation, Tissue Damage, and Fibrosis in Individuals Diagnosed with Human Immunodeficiency Virus and Pneumonia: A Cohort Study;Pathogens;2024-01-18